Pure human recombinant enzyme
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

DJ-1/PARK7 (human, recombinant)

Item No. 23589

Technical Information
Synonyms
  • Parkinson Deglycase DJ-1
  • Parkinson Disease Protein 7
Purity
≥90% estimated by SDS-PAGE
Source
Recombinant N-terminal His-tagged PARK7 enzyme expressed in E. coli
Amino Acids
2-189
MW
22 kDa
50 mM HEPES, pH 8.0, 150 mM sodium chloride, and 10% glycerol
UniProt Accession №
Q99497
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    DJ-1/Parkinson disease protein 7 (PARK7) is a dimeric protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues in oxidatively damaged proteins.1 It acts on early glycation intermediates (hemithioacetals and aminocarbinols) to prevent the formation of irreversibly damaged advanced glycation end products (AGEs). PARK7 also repairs methylglyoxal- and glyoxal-glycated dGTP, GTP, GDP, GMP, RNA, and DNA.2 Knockdown of PARK7 in vitro increases glycated DNA, DNA strand breaks, and phosphorylated p53 levels but decreases mRNA expression of the antioxidant-related enzyme NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1) and destabilizes the nuclear factor erythroid 2-related factor (Nrf2), a master regulator of antioxidant transcriptional responses.3 . PARK7 is also a glyoxalase that converts glyoxal and methylglyoxal to glycolic and lactic acid, respectively, in the absence of glutathione.4 It acts as a redox-sensitive molecular chaperone and inhibits aggregation of α-synuclein in cell-free assays and in murine neuroblastoma cells.5 PARK7 forms a complex with the E3 ubiquitin ligase Parkin and PTEN-induced putative kinase 1 (PINK1) that promotes ubiquitination and degradation of Parkin substrates, including Parkin itself and Synphilin-1 in neuroblastoma SH-SY5Y cells and human brain lysates.6 Mutations to PARK7 have been linked to autosomal recessive, early-onset Parkinson’s disease.7

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Richarme, G., Mihoub, M., Dairou, J., et alParkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues. The Journal of Biological Chemisty 290(3), 1885-1897 (2015).

    2. Richarme, G., Liu, C., Mihoub, M., et alGuanine glycation repair by DJ-1/Park7 and its bacterial homologs. Science 357(6347), 208-211 (2017).

    3. Clements, C.M., McNally, R.S., Conti, B.J., et alDJ-1, a cancer- and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. USA 103(41), 15091-15096 (2006).

    4. Lee, J.Y., Song, J., Kwon, K., et alHuman DJ-1 and its homologs are novel glyoxalases. Hum. Mol. Genet. 21(14), 3215-3225 (2012).

    5. Shendelman, S., Jonason, A., Martinat, C., et alDJ-1 is a redox-dependent molecular chaperone that inhibits α-synuclein aggregate formation. PLoS Biol. 2(11), e362 (2004).

    6. Xiong, H., Wang, D., Chen, L., et alParkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J. Clin. Invest. 119(3), 650-660 (2009).

    7. Bonifati, V., Rizzu, P., van Baren, M.J., et alMutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299(5604), 256-259 (2003).